Biggest Seed, Series A-E, and Venture Investments within Oncology June 2024.
View the report at the bottom of this page.
June 2024 Snapshot:
164 Companies across EU and US were involved in some sort of cash movements (all indications, all cash types). From this $ 2,166,258,905 total true investment received in USA and EU within the Oncology sector in June 2024 across 38 different biotechs.
Some Notable True Oncology Investments
✅ Exsilio Therapeutics - $82,000,000(Series A): advancing genomic medicinesbased on naturally occurring, programmable genetic elements
✅ FrontierMedicines - $20,000,000 (Series C): 1x Phase ½ and other preclinical programs
✅ InduPro -$85,000,000 (Series A): 1x preclinical program and the identification ofadditional candidates
✅ BrightPeak Therapeutics - $90,000,000 (Series C): 1x preclinical
✅ iOnctura -$85,897,462 (Series B): 1x Phase Ib
